Abstract-Pharmacological effects of HQ-275 on CCl<SUP>4</SUP>-liver injury have been in vestigated, and the results compared with those of rats treated with CCl<SUP>4</SUP> plus HQ -275 with those of normal rats and only CCl<SUP>4</SUP>-treated rats. In the excretion test of biliary flow, bilirubin, solid contents and B&bull;S&bull;P, rats treated with CCl<SUP>4</SUP>, alone or with CCl<SUP>4</SUP>, plus HQ-275 showed less excretion than those of normal rats, and the differences among these three categories were not significant. HQ-275 revealed a potent recovery process from the liver damage caused by CCl<SUP>4</SUP>, in both histological and biological levels. Changes of Na<SUP>+</SUP> and K<SUP>+</SUP> in bile, water content of liver and body temp. were recognized among the three groups. It can be concluded from over-all results that there may be some differences between structural and functional recovery processes from CCl<SUP>4</SUP>-hepatotoxicity.
In a previous report from our laboratory, 1-morpholinoacetyl-2-methyl-3-phenyl-4 oxo-1, 2, 3, 4-tetrahydroquinazoline hydrochloride (HQ-275) has been demonstrated to have a potent inhibitory effect against experimental hepatic injury in rats by carbon tetra chloride (CC14) with respect to histological findings (1) . CCI, is the agent most widely used to produce experimental liver damage in laboratory animals. Due to the importance of CC14 hepatotoxicity as a model for liver disease and damage, it is of interest to investigate the effect of HQ-275 on this toxicity regarding hepatic transport processes that influence biliary excretion. This paper, covers a more detailed investigation of HQ-275, choleretic actions, phenol tetrabromophthaleinsulfo nate (B . S . P)-excretion and some liver function using CC14-intoxicated rats. In addition, influence of HQ-275 on the developmental or recovery processes of hepatic injury, (administered to rats before or after CCI4-poisoning) were also studied employing transaminase levels (s-GOT and s-GPT) and histological findings as indices to evaluate the degree of the liver lesions.
MATERIALS AND METHODS
Male rats of Wistar strain (200-250 g) were mainly used for all experiments. In the series, six animals were employed as one group. They were fed on a commercial diet (CLEA, CA-1) and water ad libitum. CC],, suspended as a 10% solution in olive oil, was administered to rats orally in a dose of I g/kg (0.64 ml/100 g in olive oil) for the pur pose of creating severe hepatic injury (2) . HQ-275 was dissolved in physiological saline. Six non-treated (Gr.: A), served as control, and 18 HQ-275-treated animals were challenged with CC1,. The latter category was divided into three groups (Gr.: B HQ-275 10 mg/kg, p.o., Gr.: C 30 mg/kg, p.o. and Gr.: D 60 mg/kg, p.o., respectively). All doses of HQ-275 were administered one hr before and one hr after CCI, as a single oral admin istration for 2 days, respectively. In addition, six normal rats (Gr.: E) were prepared as control along with the other four groups. During 6-8 hr after the second CCI,-poison ing, the animals were all sacrificed except for those utilized for investigation of the influ ence of HQ-275 on histological developmental and recovery processes of CC], liver injury.
Biliary excretion: For the biliary excretion tests, the common bile ducts of the rats, anesthetized throughout with urethane (1.2 g/kg, s.c.), were cannulated centrally so that the bile could be collected via a polyethylene tube. The cystic duct was ligated and the midline abdominal incision was sutured. The animals were maintained in a relative hu midity of 60% at a room temp. of 24-: l °C. After the biliary outflow had reached a steady state, the drugs were administered into the femoral vein. Measurement of the biliary flow was made every 30 min after administration of the drugs (3, 4).
Bilirubin and solid contents: Bilirubin and solid contents which were contained in the biliary volume excreted were assayed by the modified Evelyn-Malloy's method and by the method of dry wt., respectively (5) . The outflow of the bile through common bile ducts was collected in a graduated pipette. After measurements, half of the collec tions every 30 min were used to measure bilirubin concentration and the remaining bile was dried for 10 hr in a constant oven at 105-110 'C after which each dry residue was weighed and concentration determined. Biochemical assays: Serum samples for the estimation of transaminase levels (GOT and GPT) were obtained from blood collected from rats by excising V. Jugularis under ether anesthesia just before sacrifice. The levels of transaminases were measured using the method of Reitman and Frankel and expressed in Karmen units (7).
Histological findings: It is well known that there is no direct relation between two degrees of liver lesions and the serum enzyme levels, therefore histological changes in the liver were also examined with a light microscope. A portion of liver from individual ani mals was fixed in 10% phosphate-buffer formalin and acetone and stained with sudan III, hematoxylin and eosin for microscopical studies. The extent of the necrosis produced by CCI,, (focal areas of centrilobular necrosis and ballooning) was measured using an Amsler type planimeter on a microscopical photograph of low magnification.
For histochemical analysis, alkaliphosphatase and acid phosphatase activity in the liver section was measured according to the method of Gomoris (8) . Furthermore, ap pearance of glycogen in liver tissue was demonstrated by the method of PAS-reaction (9) .
Relationship between administration time of HQ-275 and histological and biochemical activity: For the purpose of examining whether or not HQ-275 exerts a therapeutic ac tion on the damaged liver and/or the preventing effect, the drug was given to rats at various time intervals before and after CCI, administration.
In Estimation of the biliary Na' and K' con centrations was calculated from the Na+ and K' content in bile. Fici. 5. Influence of HQ-275 on s-GO I , s-01-11 and necrotic levels through the developmental and recovery processes of CC1,-liver injury in rats. The necrotic areas was measured as cm" contained in a whole area (80 cm-)). Each three column represents GOT-, GPT-activity and necrotic area, respectively. Each point represents the mean S.E. of six rats. *, indicates values to be signifi cantly different from the controls (CC], I g, kg, p.o., Gr. : A) (P 0.05).
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The results are shown in Fig. 6 . Regarding the effectiveness histological degenera tion (so-called necrosis and ballooning) as parallel levels to those of transaminase were seen, only the results of transaminase levels are shown in this figure.
In the groups of rats administered HQ-275 during the 24 hr period prior to CCI,-poisoning, neither the elevation of transaminase levels nor the histological alteration of hepatic cells were in hibited in contrast to the pronounced changes in the control, while in the groups of rats administered HQ-275 1-6 hr after CO,-poisoning, these biochemical and histological changes were inhibited markedly and, as in control, the same lesions were found unchanged. 
Water content of the liver
As shown in Table 1 , there were significant differences (p-0.05) among the normal rats, only CCI;-treated rats and the rats treated with CCI, plus HQ-275 (Gr.: E, A and C, respectively).
Percentage of water content of rat's liver treated with CCI, plus HQ 275 30 mg/kg (Gr.: C) was the lowest among these three groups.
F,leetrolytes in bile
Changes of Na' and K+ in bile among these three groups are also shown in Table   I . Each ratio of the electrolyte concentration was parallel to that of water content, re spectively.
Body temp.
As also seen in Table 1 , body temp. among these three groups was significantly recognized.
The mean temp. of rats treated with CCI, plus HQ-275 (Gr.: C) ranked in between the other two different groups. DISCUSSION As shown in Figs. I and 2, there were differences observed between normal rats (Gr.: E) and those administered CCI4, at least (Gr.: A, B and C), regarding the action of biliary excretion when an administration of HQ-275 10 mg/kg, i.v. was given. The groups of rats treated with CC14 alone (Gr.: A) and with CCI, plus HQ-275 (Gr.: B and C) did not show an increase (dose-dependently) in biliary volume as did normal rats, while the latter hastened the recovery of concentrations of bilirubin and solid contents. As this pheno menon contradicts the data shown in Fig. 2 , further investigation is now underway. As control biliary volume in rats treated with CC], plus HQ-275 (Gr.: B and C), one hr after the second CCI,-poison irig, before the experiment was greater than that of rats treated with CC14 alone (Gr.: A) and normal rats (Gr.: E), it is presumed that the ratio of biliary excretion after HQ-275 injection did not increase to any extent. In the average volume, the constant biliary output was approx. 2.5 times as great as that of nor mal rats.
In the case of B • S • P-excretion test, the effects of HQ-275 in rats treated with CCI4
plus HQ-275 (Gr.: B and C) were similar to those seen in rats administered CCI, alone (Gr.: A). It is well known that there is not necessarily a relationship between the degree of pro tection against histological changes and the transaminase levels. Treatment of rats with CCI, plus HQ-275, however, markedly decreased the extent of the histological changes produced by CC14, which showed centrilobular necrosis surrounded by the cell balloon ing, glycogen and acid phosphatase deposition. Furthermore, HQ-275 protected the liver of rats from the toxic action of CCI4 by preventing an increase in transaminase levels in parallel with the case of protection against necrosis.
From the fact that a pre-administration of HQ-275 did not protect the liver from the toxicity of CCl4 in spite of revealing a strong protective effect in cases of post-administra tion, it may be concluded that HQ-275 has a therapeutic effect rather than a protective one. In addition, HQ-275 was demonstrated as not acting at the early stages of the patho genetic process of CCI, liver injury. Considering these results, it would appear that the action mechanism of HQ-275 on CCI4-intoxication, would prevent degeneration of the hepatic cells which were thought to be the result of another mechanism (12) rather than the leakage of hepatocellular enzymes due to the CC],-induced alterations of hepatic mem brane systems. The changes of Na', K+, bilirubin and solid contents in bile, water content of liver and body temp. between normal (Gr.: E) and CCI4-treated animals (Gr.: A and C) were examined. Among these three groups, a relationship was markedly recognized. It is postulated that the lowest biliary content of rats treated with CC], plus HQ-275 (Gr.: C) among these three groups was the result of the potent hydrocholeretic action of HQ 275 administered one hr prior to and 5 hr after CCI4-administration.
